AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Collegium Pharmaceutical Announces Management Participation in Investor Conferences.
ByAinvest
Thursday, Aug 28, 2025 8:03 am ET1min read
Collegium Pharmaceutical announced that its management team will participate in the 2025 Wells Fargo Healthcare Conference, Morgan Stanley 23rd Annual Global Healthcare Conference, and H.C. Wainwright 27th Annual Global Investment Conference. A live webcast of the fireside chats will be available on the company's website.
Collegium Pharmaceutical, Inc. (Nasdaq: COLL) has announced that its management team will participate in several high-profile investor conferences this September. The company will be present at the 2025 Wells Fargo Healthcare Conference, the Morgan Stanley 23rd Annual Global Healthcare Conference, and the H.C. Wainwright 27th Annual Global Investment Conference [1].The 2025 Wells Fargo Healthcare Conference is scheduled for Thursday, September 4, 2025, in Boston, MA. The Morgan Stanley event will feature a fireside chat on Monday, September 8, 2025, at 2:35 p.m. ET in New York, NY. The H.C. Wainwright conference will host a fireside chat on Tuesday, September 9, 2025, at 10:30 a.m. ET in New York, NY [1].
Collegium Pharmaceutical is a leading biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has a strong portfolio of responsible pain management medications and a growing neuropsychiatry business, driven by its differentiated treatment for ADHD, Jornay PM® [1].
For investors who cannot attend these events in person, Collegium Pharmaceutical will provide live webcasts of the fireside chats. The live webcasts will be available via the Investors section of the company's website, with replays archived for 90 days following the presentations [1].
References:
[1] https://www.marketscreener.com/news/collegium-to-participate-in-upcoming-investor-conferences-ce7c50dfd18bf223
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet